■ 刊行論文
|
原著
|
|
1.
|
Takatoshi Somoto, Takanobu Utsumi, Rino Ikeda, Naoki Ishitsuka, Takahide Noro, Yuta Suzuki, Shota Iijima, Yuka Sugizaki, Ryo Oka, Takumi Endo, Naoto Kamiya, Nobuyuki hiruta† and Hiroyoshi Suzuki.：
Development of a Nomogram for Predicing Lymphovascular Invasion Initial Transurethral Resection of Bladder Tumors.
Applied sciences
15
(24)
：1
-13
, 2025
|
|
2.
|
Takahide Noro†, Takanobu Utsumi†, Naoki Ishitsuka†, Yuka Suzuki†, Shota Iijima†, Yuka Sugizaki†, Takatoshi Somoto†, Ryo Oka†, Takumi Endo†, Naoto Kamiya†, Nobuyuki Hiruta†, Hroyoshi Suzuki†：
Impact of the COVID-19 Pandemic on Prostate Cancer:Perturbations in Screening and Diagnostic Patterns.
International Journal of Urology
0
：1
-7
, 2025
|
|
3.
|
Takatoshi Somoto†, Takanobu Utsumi†, Naoki Ishitsuka†, Takahide Noro†, Yuka Suzuki†, Shota Iijima†, Yuka Sugizaki†, Ryo Oka†, Takumi Endo†, Naoto Kamiya†, Naomi Shimizu†, Nobuyuki Hiruta†, Hroyoshi Suzuki†：
Clinical Predictors of Fluoroquinolone-Resistant Escherichia coli in Transrectal Ultrasound-Guided Prostate Biopsy: Insights for Tailored Prophylaxis.
International Journal of Urology
0
：1
-8
, 2025
|
|
症例報告
|
|
1.
|
Kensuke Namba, Kazutoshi Isobe, Sanshiro Nakao, Nobuyuki Hiruta†,
Hiroyuki Wakabayashi.：
Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma : A Case Report and Literature Review.
Cureus Part of SPRINGER NATURE
：1
-7
, 2025
|
|
2.
|
Taiki Nabekura, Yu Sato, Nobuyuki Hiruta, Natsumi Kitahara, Yuki Moriyama, Kengo Kadoya, Ayami Sato, Kotaro Wakamatsu, Masaru Tsuchiya：
Successful Treatment of Locally Advanced Microsatellite Instability-High Ascending Colon Cancer Using an Immune Checkpoint Inhibitor without Extensive Resection: A Case Report.
Surgical case reports
：
, 2025
|
|
■ 学会発表
|
国内学会
|
|
1.
|
◎吉濵絵理†，吉田憲司†，吉川征吾†，種瀬啓士†，定本聡太†（同病理），密田亜希†（同病理），蛭田啓之†（佐倉病院病理），石河 晃†：
前腕に生じた皮下結節.
第41回日本皮膚病理組織学会総会・学術大会,
大阪,
2025/04
|
|
その他
|
|
1.
|
◎田中宏, 榊原雅裕, 平塚萌子, 森山雄貴, 土屋勝, 蛭田啓之,：
乳癌術後膵転移の1例.
第47回日本癌局所療法研究会,
千葉,
2025/05
|
|
